National Cancer Waiting Times Monitoring Data Set Scenarios

Description

National Cancer Waiting Times Monitoring Data Set: Concept of Operation and Patient Pathway Scenarios

The National Cancer Waiting Times Monitoring Data Set  is a generic data set designed to support the monitoring of waiting times for a variety of different pathways of cancer care. For the purpose of this data collection cancer is defined using the International Classification of Diseases (ICD) codes. The full list of  International Classification of Diseases (ICD) diagnosis codes is available on the NHS Digital  website at:  Cancer Waiting Times.

Collection and submission of the National Cancer Waiting Times Monitoring Data Set is to be managed according to the maximum waiting time and information requirements of the pathway of care for each individual PATIENT. These requirements for providers of cancer SERVICES to return data to the Cancer Waiting Times Database are defined using different scenarios.

The columns in the table below show which data items are required for a range of health care scenarios:

Data Set Notation:

  • M = Mandatory:

    the Standard Contract Schedule 5 requires NHS provider ORGANISATIONS to submit this information on a monthly basis. NHS England and NHS Improvement require the data to be submitted a number of working days after the end of each month or quarter. This submission schedule is set out on the NHS Digital website at: Cancer Waiting Times Data Collection (CWT).

  • M* = Mandatory if applicable:

    the Standard Contract Schedule 5 requires NHS provider ORGANISATIONS to submit this information on a monthly basis, where collection of the item was applicable to them. NHS England and NHS Improvement  require the data to be submitted a number of working days after the end of each month or quarter. This submission schedule is set out on the NHS Digital website at: Cancer Waiting Times Data Collection (CWT).

  • O = Optional
  • O* = Optional if applicable:

    These optional fields should only be populated if they relate to the PATIENT PATHWAY identified in the scenarios and the conditions required for their use are met.

  • N/A = Not Applicable

Note: Inter-Provider Transfers:

Data Item

Scenario 1a

Scenario 1b

Scenario 1c

Scenario 1d

Scenario 1e

Scenario 1f

Scenario 1g

Scenario 2a

Scenario 2b

Scenario 3

Scenario 4

Scenario 5

Scenario 6

Scenario 7

NHS NUMBER

M

M

M

M

M

M

M

M

M

M

M

M

M

M

NHS NUMBER STATUS INDICATOR CODE

M

M

M

M

M

M

M

M

M

M

M

M

M

M

PATIENT PATHWAY IDENTIFIER

M

M

M

M

M

M

M

M*

M*

M*

M*

M*

M*

M*

ORGANISATION IDENTIFIER (PATIENT PATHWAY IDENTIFIER ISSUER)

M

M

M

M

M

M

M

M*

M*

M*

M*

M*

M*

M*

SOURCE OF REFERRAL FOR OUT-PATIENTS

M

M

M

M

M

N/A

M

N/A

N/A

N/A

M

N/A

O

N/A

PRIORITY TYPE CODE

M

M

M

M

M

N/A

M

N/A

N/A

N/A

M

N/A

O

N/A

DECISION TO REFER DATE (CANCER OR BREAST SYMPTOMS)

M*

M*

M*

M*

M*

N/A

M*

N/A

N/A

N/A

N/A

N/A

O

N/A

CANCER REFERRAL TO TREATMENT PERIOD START DATE

M

M

M

M

M

N/A

M

M

N/A

N/A

O

N/A

O

N/A

TWO WEEK WAIT CANCER OR SYMPTOMATIC BREAST REFERRAL TYPE

M

M

M

M

M

N/A

M

N/A

N/A

N/A

N/A

N/A

O

N/A

CONSULTANT UPGRADE DATE

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

M

N/A

O

N/A

ORGANISATION SITE IDENTIFIER (OF PROVIDER CONSULTANT UPGRADE)

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

M

N/A

O

N/A

DATE FIRST SEEN

M

M

M

M

M

N/A

M

N/A

N/A

N/A

M

N/A

O

N/A

ORGANISATION SITE IDENTIFIER (OF PROVIDER FIRST SEEN)

M

M

M

M

M

N/A

M

N/A

N/A

N/A

M

N/A

N/A

N/A

WAITING TIME ADJUSTMENT (FIRST SEEN)

M*

M*

M*

M*

M*

N/A

M*

N/A

N/A

N/A

O*

N/A

N/A

N/A

WAITING TIME ADJUSTMENT REASON (FIRST SEEN)

M*

M*

M*

M*

M*

N/A

M*

N/A

N/A

N/A

O*

N/A

N/A

N/A

CANCER CARE SPELL DELAY REASON (FIRST SEEN)

M*

M*

M*

M*

M*

N/A

M*

N/A

N/A

N/A

N/A

N/A

N/A

N/A

CANCER CARE SPELL DELAY REASON COMMENT (FIRST SEEN)

O*

O*

O*

O*

O*

N/A

O*

N/A

N/A

N/A

N/A

N/A

N/A

N/A

CANCER DIAGNOSTIC REFERRAL ROUTE

O*

O*

M*

O*

O*

N/A

O*

O*

N/A

N/A

N/A

N/A

O*

N/A

RAPID DIAGNOSTIC CENTRE PATHWAY COMPLIANCE INDICATOR

O*

O*

O*

O*

O*

N/A

O*

O*

N/A

N/A

N/A

N/A

O*

N/A

CANCER OR SYMPTOMATIC BREAST REFERRAL PATIENT STATUS

M

M

M

M

M

M

M

M

M

M

M

M

M

M

PRIMARY DIAGNOSIS (ICD)

N/A

M*

N/A

M*

N/A

N/A

N/A

M

M

M

M

M

M

M

TUMOUR LATERALITY

N/A

M*

N/A

M*

N/A

N/A

N/A

M

M

M

M

M

M

M

CANCER TREATMENT PERIOD START DATE

N/A

N/A

N/A

M

N/A

N/A

N/A

M

M

M

M

M

M

M

ORGANISATION SITE IDENTIFIER (OF PROVIDER CANCER DECISION TO TREAT)

N/A

N/A

N/A

M

N/A

N/A

N/A

M

M

M

M

M

M

M

REFERRAL REQUEST RECEIVED DATE (INTER-PROVIDER TRANSFER)

 #

N/A

N/A

N/A

N/A

N/A

M

N/A

N/A

M

N/A

N/A

N/A

N/A

N/A

PROSTATE CANCER CLINICAL RISK CATEGORY

M*

M*

M*

M*

M*

N/A

M*

M*

M*

M*

M*

M*

M*

M*

CANCER FASTER DIAGNOSIS PATHWAY END REASON

N/A

M

N/A

M

N/A

N/A

M

M

M

M*

N/A

N/A

N/A

N/A

PRIMARY CANCER SITE (CANCER FASTER DIAGNOSIS PATHWAY)

N/A

M

N/A

M

N/A

N/A

N/A

M

M

N/A

N/A

N/A

N/A

N/A

CANCER FASTER DIAGNOSIS PATHWAY END DATE

N/A

M

N/A

M

N/A

N/A

M

M

M

M*

N/A

N/A

N/A

N/A

CANCER CARE SPELL DELAY REASON (OUTCOME COMMUNICATION CANCER FASTER DIAGNOSIS PATHWAY)

N/A

M*

N/A

M*

N/A

N/A

N/A

M*

M*

N/A

N/A

N/A

N/A

N/A

CANCER CARE SPELL DELAY REASON COMMENT (OUTCOME COMMUNICATION CANCER FASTER DIAGNOSIS PATHWAY)

N/A

O*

N/A

O*

N/A

N/A

N/A

O*

O*

N/A

N/A

N/A

N/A

N/A

CANCER FASTER DIAGNOSIS PATHWAY EXCLUSION REASON

N/A

N/A

N/A

N/A

N/A

N/A

M

N/A

N/A

M*

N/A

N/A

N/A

N/A

CARE PROFESSIONAL TYPE (OUTCOME COMMUNICATION CANCER FASTER DIAGNOSIS PATHWAY)

N/A

O*

N/A

O*

N/A

N/A

N/A

O*

O*

N/A

N/A

N/A

N/A

N/A

METHOD OF COMMUNICATION (END OF CANCER FASTER DIAGNOSIS PATHWAY)

N/A

O*

N/A

O*

N/A

N/A

N/A

O*

O*

N/A

N/A

N/A

N/A

N/A

ORGANISATION SITE IDENTIFIER (OF CANCER FASTER DIAGNOSIS PATHWAY END DATE)

N/A

M

N/A

M

N/A

N/A

M

M

M

M*

N/A

N/A

N/A

N/A

SERVICE REQUESTED DATE (INTER-PROVIDER TRANSFER)

 #

N/A

N/A

N/A

N/A

M

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

ORGANISATION IDENTIFIER (REFERRING)

 #

N/A

N/A

N/A

N/A

M

M

N/A

N/A

M

N/A

N/A

N/A

N/A

N/A

ORGANISATION IDENTIFIER (RECEIVING)

 #

N/A

N/A

N/A

N/A

M

M

N/A

N/A

M

N/A

N/A

N/A

N/A

N/A

CANCER TRANSFER REFERRING REASON (INTER-PROVIDER TRANSFER)

 #

N/A

N/A

N/A

N/A

O

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

CANCER TRANSFER RECEIVING REASON (INTER-PROVIDER TRANSFER)

 #

N/A

N/A

N/A

N/A

N/A

O

N/A

N/A

O

N/A

N/A

N/A

N/A

N/A

REFERRAL REQUEST RECEIVED DATE (INTER-PROVIDER TRANSFER)

 ##

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

SERVICE REQUESTED DATE (INTER-PROVIDER TRANSFER)

 ##

N/A

N/A

N/A

N/A

N/A

M

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

ORGANISATION IDENTIFIER (REFERRING)

 ##

N/A

N/A

N/A

N/A

N/A

M

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

ORGANISATION IDENTIFIER (RECEIVING)

 ##

N/A

N/A

N/A

N/A

N/A

M

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

CANCER TRANSFER REFERRING REASON (INTER-PROVIDER TRANSFER)

 ##

N/A

N/A

N/A

N/A

N/A

O

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

CANCER TRANSFER RECEIVING REASON (INTER-PROVIDER TRANSFER)

 ##

N/A

N/A

N/A

N/A

N/A

O

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

TREATMENT START DATE (CANCER)

N/A

N/A

N/A

N/A

N/A

N/A

N/A

M

M

M

M

M

M

M

ORGANISATION SITE IDENTIFIER (OF PROVIDER CANCER TREATMENT START DATE)

N/A

N/A

N/A

N/A

N/A

N/A

N/A

M

M

M

M

M

M

M

CANCER TREATMENT EVENT TYPE

N/A

N/A

N/A

N/A

N/A

N/A

N/A

M

M

M

M

M

M

M

CANCER TREATMENT MODALITY

N/A

N/A

N/A

N/A

N/A

N/A

N/A

M

M

M

M

M

M

M

CLINICAL TRIAL INDICATOR

N/A

N/A

N/A

N/A

N/A

N/A

N/A

M

M

M

M

M

M

M

CANCER CARE SETTING (TREATMENT)

N/A

N/A

N/A

N/A

N/A

N/A

N/A

M

M

M

M

M

M

M

CANCER CARE SPELL DELAY REASON (DECISION TO TREATMENT)

N/A

N/A

N/A

N/A

N/A

N/A

N/A

M*

M*

M*

M*

M*

M*

M*

CANCER CARE SPELL DELAY REASON COMMENT (DECISION TO TREATMENT)

N/A

N/A

N/A

N/A

N/A

N/A

N/A

O*

O*

O*

O*

O*

O*

O*

WAITING TIME ADJUSTMENT (TREATMENT)

N/A

N/A

N/A

N/A

N/A

N/A

N/A

M*

M*

M*

M*

M*

M*

M*

WAITING TIME ADJUSTMENT REASON (TREATMENT)

N/A

N/A

N/A

N/A

N/A

N/A

N/A

M*

M*

M*

M*

M*

M*

M*

CANCER CARE SPELL DELAY REASON (REFERRAL TO TREATMENT)

N/A

N/A

N/A

N/A

N/A

N/A

N/A

M*

M*

N/A

M*

N/A

O*

N/A

CANCER CARE SPELL DELAY REASON COMMENT (REFERRAL TO TREATMENT)

N/A

N/A

N/A

N/A

N/A

N/A

N/A

O*

O*

N/A

O*

O*

O*

N/A

CANCER CARE SPELL DELAY REASON (CONSULTANT UPGRADE)

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

M*

N/A

O*

N/A

CANCER CARE SPELL DELAY REASON COMMENT (CONSULTANT UPGRADE)

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

O*

N/A

O*

N/A

Full details of the validation rules and processes are available on the NHS Digital  website at: Cancer Waiting Times.

Also Known As

This Supporting information is also known by these names:

Context Alias
Full name National Cancer Waiting Times Monitoring Data Set: Scenarios
Short name Patient Pathway Scenarios